Lactulose Viatris Sante (Lactulose)

After oral ingestion, lactulose reaches the colon where intestinal bacteria ferment it into short‑chain fatty acids. This process lowers the colonic pH, creating an osmotic gradient that draws water into the lumen, softening stool. The acidic environment also converts ammonia to ammonium, which is trapped in the gut and eliminated, thereby decreasing systemic ammonia.

The dose of lactulose is individualized by the prescribing clinician based on the patient’s condition, age, renal function, and response. Healthcare providers determine the appropriate amount and frequency, and patients should follow the prescribed regimen without alteration.

Safety data for lactulose in pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss use with their healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Lactulose is an osmotic laxative that works by retaining water in the colon, whereas stimulant laxatives (e.g., bisacodyl) increase intestinal motility. Compared with fiber supplements, lactulose provides a more rapid softening effect. Choice of therapy depends on patient tolerance, underlying conditions, and clinician preference.

Lactulose Viatris Sante should be stored at room temperature, below 25 °C, in its original packaging. Protect the product from moisture, excessive heat, and direct sunlight to maintain stability. No refrigeration is required for this oral formulation.

The medication is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and may be mixed with water or a suitable beverage if needed for palatability. Patients should follow the dosing instructions provided by their prescriber.

Serious risks include severe dehydration, electrolyte disturbances (especially low sodium or potassium), and rare allergic reactions such as rash or swelling. Patients experiencing persistent diarrhea, dizziness, or signs of an allergic response should seek medical attention promptly.

Lactulose is contraindicated in individuals with known galactosemia because it contains galactose residues. Patients with severe intestinal obstruction, acute abdominal conditions, or hypersensitivity to lactulose should also avoid its use. Clinicians must evaluate each patient’s medical history before prescribing.